- Events known as AESI are those that might be causally linked to a vaccine product and happen after vaccination.
- In adults, the most prevalent AESIs were nervous system illnesses (5.5%), musculoskeletal disorders (5.8%), and general disorders (8.9).
- Notably, 4.6% of the female participants had irregular menstruation.
According to research done on the BBV152 anti-COVID vaccination by Bharat Biotech, around one-third of the 926 people who received the shot reported adverse events of special interest (AESI). Events known as AESI are those that might be causally linked to a vaccine product and happen after vaccination.
Roughly 1% of people had a history of serious AESI, which included stroke and Guillain-Barre syndrome. The three most frequent disorders seen in teenagers following vaccination were general disorders, nervous system disorders, and new-onset skin and subcutaneous illnesses.
Covaxin
The long-term safety of the BBV152 vaccination in adults and adolescents was examined in a study that was published in the Journal of Springer Nature. It was discovered that during the follow-up period, about 50% of the sample size reported having illnesses, with viral upper respiratory tract infections being the most common type.
Bharat Biotech clarified, however, that several studies on the safety of Covaxin have been conducted and published in peer-reviewed publications, exhibiting a strong safety record.
AESIs that were often reported included adult and adolescent patients with newly developed skin and subcutaneous issues (10.5%), general disorders (10.2%), and nervous system ailments (4.7%).
In adults, the most prevalent AESIs were nervous system illnesses (5.5%), musculoskeletal disorders (5.8%), and general disorders (8.9). Notably, 4.6% of the female participants had irregular menstruation. In 2.7% and 0.6% of subjects, respectively, ocular anomalies and hypothyroidism were found.
Dr. Vanita Arora, senior consultant cardiac electrophysiologist and interventional cardiologist at Apollo Hospital, Delhi, stated that the creation of COVID-19 immunizations was essential to controlling the pandemic. Monitoring and understanding the long-term adverse effects is critical, like with any medical procedure, to ensure patient safety and effectively address concerns.
Especially in patients with cardiovascular risk factors, strokes classified as AESI give rise to serious concerns. If a patient has ever experienced atrial fibrillation, diabetes, or hypertension, they should exercise extra caution. It is recommended to manage cardiovascular risk factors and have regular check-ups.
People who already have health problems appear to be more susceptible to AESI after receiving Covaxin medication. This is especially important for patients with chronic diseases such as diabetes, heart disease, and autoimmune disorders. The benefits of vaccination considerably outweigh the risks because they protect us from serious health consequences, even though these side effects are vital to take into account.
